Compare, Analyse Biocon Ltd with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs ADCOCK INGRAM (S. Africa) - Comparison Results

BIOCON      Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 BIOCON    ADCOCK INGRAM
EQUITY SHARE DATA
    BIOCON
Mar-19
ADCOCK INGRAM
Jun-14
BIOCON /
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs707320-   
Low Rs554231-   
Sales per share (Unadj.) Rs91.995.3-  
Earnings per share (Unadj.) Rs16.7-24.0-  
Cash flow per share (Unadj.) Rs24.2-19.9-  
Dividends per share (Unadj.) Rs1.000-  
Dividend yield (eoy) %0.20-  
Book value per share (Unadj.) Rs101.674.8-  
Shares outstanding (eoy) m600.00168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x6.92.9 237.1%   
Avg P/E ratio x37.7-11.5 -328.6%  
P/CF ratio (eoy) x26.1-13.9 -188.3%  
Price / Book Value ratio x6.23.7 168.3%  
Dividend payout %6.00-   
Avg Mkt Cap Rs m378,33046,551 812.7%   
No. of employees `0006.14.3 142.8%   
Total wages/salary Rs m11,6532,922 398.9%   
Avg. sales/employee Rs Th8,994.33,747.7 240.0%   
Avg. wages/employee Rs Th1,900.7680.6 279.3%   
Avg. net profit/employee Rs Th1,635.3-944.3 -173.2%   
INCOME DATA
Net Sales Rs m55,14416,089 342.7%  
Other income Rs m1,444113 1,281.7%   
Total revenues Rs m56,58816,201 349.3%   
Gross profit Rs m15,883-2,788 -569.7%  
Depreciation Rs m4,478694 644.9%   
Interest Rs m709436 162.7%   
Profit before tax Rs m12,140-3,806 -319.0%   
Minority Interest Rs m9-11 -84.8%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,123238 892.8%   
Profit after tax Rs m10,026-4,054 -247.3%  
Gross profit margin %28.8-17.3 -166.2%  
Effective tax rate %17.5-6.2 -279.9%   
Net profit margin %18.2-25.2 -72.2%  
BALANCE SHEET DATA
Current assets Rs m48,22811,784 409.3%   
Current liabilities Rs m30,3766,630 458.2%   
Net working cap to sales %32.432.0 101.1%  
Current ratio x1.61.8 89.3%  
Inventory Days Days68111 61.6%  
Debtors Days Days86124 69.0%  
Net fixed assets Rs m64,1306,869 933.7%   
Share capital Rs m3,00075 4,016.2%   
"Free" reserves Rs m57,9800-   
Net worth Rs m60,98012,628 482.9%   
Long term debt Rs m15,7664,438 355.3%   
Total assets Rs m121,92423,855 511.1%  
Interest coverage x18.1-7.7 -234.4%   
Debt to equity ratio x0.30.4 73.6%  
Sales to assets ratio x0.50.7 67.1%   
Return on assets %8.8-15.2 -58.0%  
Return on equity %16.4-32.1 -51.2%  
Return on capital %16.8-19.8 -84.6%  
Exports to sales %28.10-   
Imports to sales %18.90-   
Net fx Rs m5,1070-   
CASH FLOW
From Operations Rs m11,5461,373 840.8%  
From Investments Rs m-7,138-422 1,692.8%  
From Financial Activity Rs m-2,4174,028 -60.0%  
Net Cashflow Rs m2,1034,979 42.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.42 Rs / ZAR

Compare BIOCON With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare BIOCON With: DR. DATSONS LABS  SUVEN LIFESCIENCES  ORCHID PHARMA LTD  VENUS REMEDIES  AUROBINDO PHARMA  



Today's Market

Sensex Ends 429 Points Higher; Auto and IT Stocks Rally(Closing)

Indian share markets extended gains for the second consecutive day and ended on a strong note, tracking gains in Asian peers and Wall Street.

Related Views On News

BIOCON Announces Quarterly Results (3QFY20); Net Profit Up 1.2% (Quarterly Result Update)

Jan 24, 2020 | Updated on Jan 24, 2020

For the quarter ended December 2019, BIOCON has posted a net profit of Rs 2 bn (up 1.2% YoY). Sales on the other hand came in at Rs 17 bn (up 13.5% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

BIOCON Announces Quarterly Results (2QFY20); Net Profit Down 30.5% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, BIOCON has posted a net profit of Rs 3 bn (down 30.5% YoY). Sales on the other hand came in at Rs 16 bn (up 19.0% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

More Views on News

Most Popular

This is How You Should Trade Intraday (Fast Profits Daily)

Jun 19, 2020

In this video, I'll show you how to trade the market intraday like a professional trader.

Be Prepared to Profit from the Coming Crash in Oil Prices (Fast Profits Daily)

Jun 25, 2020

The stability in crude oil prices will not last much longer. Be ready to make fast profits when the time comes to short crude.

Tata Motors Tripled in 18 Months but You Can Do Even Better. Here's How... (Profit Hunter)

Jun 24, 2020

Rahul is ready for a repeat of his famous 2008 Tata Motors call.

This Ratio Says Smallcaps Are Your Best Bet to Ride the Post Covid Market Rebound (Profit Hunter)

Jun 23, 2020

Here's why I believe that post Covid rebound in smallcaps will be much sharper than largecaps.

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2020
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
A Guide to some of the Most Lucrative Stocks in the Market. Download For Free!
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

BIOCON SHARE PRICE


Jul 2, 2020 (Close)

TRACK BIOCON

MORE ON BIOCON

BIOCON 8-QTR ANALYSIS

COMPARE BIOCON WITH

FEATURED VIDEOS

MARKET STATS